GGrantIndex
← Leaderboards

Phillip A. Scott

University Of Pennsylvania

$24,920,033
Attributed
$28,112,095
Total exposure
27
Grants
23
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,112,095 · 27

By mechanism

R01$22,056,203 · 12
U01$4,349,502 · 1
R21$836,250 · 2
S10$407,390 · 1
R56$393,750 · 1
R13$69,000 · 10

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Leishmaniasis

Research focus

LeishmaniasisParasitesImmune ResponseInfectionMediatingResponseLesionCellsProductionDesignNeglected Tropical DiseasesPlayCutaneous LeishmaniasisImmunotherapyT-LymphocyteCytokineLeishmaniaPathologicDisease ProgressionImmunopathologyInflammatoryBasePathologyCutaneous

Grant awards (81)

Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$805,550
R01 · FY2025 · AI · contact PI
Deciphering the ontogeny of CD4+ resident memory T cells that globally seed the skin and protect against cutaneous leishmaniasis$769,366
R01 · FY2025 · AI · contact PI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$807,175
R01 · FY2024 · AI · contact PI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis$557,812
R01 · FY2024 · AI · contact PI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$708,674
R01 · FY2023 · AI · contact PI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis$557,812
R01 · FY2023 · AI · contact PI
Host and parasite factors promoting disease and treatment failure in Leishmania braziliensis patients$155,243
R01 · FY2023 · AI · contact PI
2023 Woods Hole Immunoparasitology Meeting$7,000
R13 · FY2023 · AI · contact PI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$708,674
R01 · FY2022 · AI · contact PI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis$557,812
R01 · FY2022 · AI · contact PI
Host and parasite factors promoting disease and treatment failure in Leishmania braziliensis patients$157,680
R01 · FY2022 · AI · contact PI
Parasite polymorphism and host immune response in cutaneous leishmaniasis outcome$118,530
R01 · FY2022 · AI
2022 WOODS HOLE IMMUNOPARASITOLOGY MEETING$6,000
R13 · FY2022 · AI · contact PI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$707,984
R01 · FY2021 · AI · contact PI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis$557,097
R01 · FY2021 · AI · contact PI
Host and parasite factors promoting disease and treatment failure in Leishmania braziliensis patients$158,208
R01 · FY2021 · AI · contact PI
Parasite polymorphism and host immune response in cutaneous leishmaniasis outcome$118,530
R01 · FY2021 · AI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$706,604
R01 · FY2020 · AI · contact PI
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis$556,096
R01 · FY2020 · AI · contact PI
Resident Memory T cells in Leishmaniasis$402,500
R01 · FY2020 · AI · contact PI
Host and parasite factors promoting disease and treatment failure in Leishmania braziliensis patients$155,044
R01 · FY2020 · AI · contact PI
Parasite polymorphism and host immune response in cutaneous leishmaniasis outcome$118,530
R01 · FY2020 · AI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis$720,639
R01 · FY2019 · AI · contact PI
Resident Memory T cells in Leishmaniasis$402,500
R01 · FY2019 · AI · contact PI
The Role of Innate Cells in the Pathogenesis of Leishmania Braziliensis Infection$346,611
U01 · FY2019 · AI · contact PI
Parasite polymorphism and host immune response in cutaneous leishmaniasis outcome$118,530
R01 · FY2019 · AI
23rd Annual Woods Hole Immunoparasitology (WHIP) Meeting$7,500
R13 · FY2019 · AI · contact PI
Resident Memory T cells in Leishmaniasis$402,500
R01 · FY2018 · AI · contact PI
The Role of Innate Cells in the Pathogenesis of Leishmania Braziliensis Infection$346,611
U01 · FY2018 · AI · contact PI
Parasite polymorphism and host immune response in cutaneous leishmaniasis outcome$118,530
R01 · FY2018 · AI
22nd Annual Woods Hole Immunoparasitology (WHIP) Meeting$5,500
R13 · FY2018 · AI · contact PI
Resident Memory T cells in Leishmaniasis$402,500
R01 · FY2017 · AI · contact PI
Protective and Pathologic Roles for CD8+ T cells in Leishmaniasis$400,000
R01 · FY2017 · AI · contact PI
The Role of Innate Cells in the Pathogenesis of Leishmania Braziliensis Infection$346,611
U01 · FY2017 · AI · contact PI
21st Annual Woods Hole Immunoparasitology (WHIP) Meeting$5,000
R13 · FY2017 · AI · contact PI
Resident Memory T cells in Leishmaniasis$402,083
R01 · FY2016 · AI · contact PI
Protective and Pathologic Roles for CD8+ T cells in Leishmaniasis$400,000
R01 · FY2016 · AI · contact PI
The Role of Innate Cells in the Pathogenesis of Leishmania Braziliensis Infection$349,995
U01 · FY2016 · AI · contact PI
20th Annual Woods Hole Immunoparasitology Meeting$5,000
R13 · FY2016 · AI · contact PI
Myeloid-lineage cells and immunopathology in Leishmania braziliensis$572,098
U01 · FY2015 · AI · contact PI
Protective and Pathologic Roles for CD8+ T cells in Leishmaniasis$400,000
R01 · FY2015 · AI · contact PI
Resident memory T cells in leishmaniasis$200,000
R21 · FY2015 · AI · contact PI
Annual Woods Hole Immunoparasitology (WHIP) Meeting$5,000
R13 · FY2015 · AI · contact PI
Myeloid-lineage cells and immunopathology in Leishmania braziliensis$572,099
U01 · FY2014 · AI · contact PI
Protective and Pathologic Roles for CD8+ T cells in Leishmaniasis$400,000
R01 · FY2014 · AI · contact PI
Resident memory T cells in leishmaniasis$240,000
R21 · FY2014 · AI · contact PI
Annual Woods Hole Immunoparasitology (WHIP) Meeting$10,000
R13 · FY2014 · AI · contact PI
Myeloid-lineage cells and immunopathology in Leishmania braziliensis$576,914
U01 · FY2013 · AI · contact PI
Initiation of Immune Response in Chronic Leishmaniasis$362,760
R01 · FY2013 · AI · contact PI
IL-12 as an immunopotentiator in leishmaniasis$362,760
R01 · FY2013 · AI · contact PI
Myeloid-lineage cells and immunopathology in Leishmania braziliensis$601,620
U01 · FY2012 · AI · contact PI
Initiation of Immune Response in Chronic Leishmaniasis$385,914
R01 · FY2012 · AI · contact PI
IL-12 as an immunopotentiator in leishmaniasis$385,914
R01 · FY2012 · AI · contact PI
Annual Woods Hole Immunoparasitology (WHIP) Meeting$8,000
R13 · FY2012 · AI · contact PI
Myeloid-lineage cells and immunopathology in Leishmania braziliensis$636,943
U01 · FY2011 · AI · contact PI
Initiation of Immune Response in Chronic Leishmaniasis$385,914
R01 · FY2011 · AI · contact PI
IL-12 as an immunopotentiator in leishmaniasis$385,914
R01 · FY2011 · AI · contact PI
Annual Woods Hole Immunoparasitology (WHIP) Meeting$10,000
R13 · FY2011 · AI · contact PI
Initiation of Immune Response in Chronic Leishmaniasis$389,813
R01 · FY2010 · AI · contact PI
IL-12 as an immunopotentiator in leishmaniasis$389,813
R01 · FY2010 · AI · contact PI
IL-12 as an immunopotentiator in leishmaniasis$393,750
R01 · FY2009 · AI · contact PI
Initiation of Immune Response in Chronic Leishmaniasis$196,875
R01 · FY2009 · AI · contact PI
Initiation of Immune Response in Chronic Leishmaniasis$42,180
R01 · FY2009 · AI · contact PI
Initiation Of Immune Responses in Chronic Leishmaniasis$393,750
R56 · FY2008 · AI · contact PI
Gammacell-40 Exactor Research Irradiator$407,390
S10 · FY2007 · RR · contact PI
IL-12 as an immunopotentiator in leishmaniasis$375,716
R01 · FY2007 · AI · contact PI
Vaccine Development in Leishmaniasis$386,938
R01 · FY2006 · AI · contact PI
IL-12 as an immunopotentiator in leishmaniasis$386,938
R01 · FY2006 · AI · contact PI
Vaccine Development in Leishmaniasis$396,250
R01 · FY2005 · AI
IL-12 as an immunopotentiator in leishmaniasis$396,250
R01 · FY2005 · AI
Vaccine Development in Leishmaniasis$396,250
R01 · FY2004 · AI
IL-12 as an immunopotentiator in leishmaniasis$396,250
R01 · FY2004 · AI
IL-12 as an immunopotentiator in leishmaniasis$264,167
R01 · FY2003 · AI
GAMMA/DELTA T CELLS AND PATHOGEN INDUCED IMMUNE RESPONSE$206,537
R01 · FY2003 · AI
IL-12 as an immunopotentiator in leishmaniasis$396,250
R21 · FY2002 · AI
GAMMA/DELTA T CELLS AND PATHOGEN INDUCED IMMUNE RESPONSE$200,517
R01 · FY2002 · AI
IL12 AS AN IMMUNOPOTENTIATOR IN LEISHMANIASIS$379,801
R01 · FY2001 · AI
GAMMA/DELTA T CELLS AND PATHOGEN INDUCED IMMUNE RESPONSE$194,680
R01 · FY2001 · AI
IL12 AS AN IMMUNOPOTENTIATOR IN LEISHMANIASIS$368,737
R01 · FY2000 · AI
IMMUNOPATHOGENESIS OF CHRONIC LEISHMANIASIS$269,728
R01 · FY2000 · AI
GAMMA/DELTA T CELLS AND PATHOGEN INDUCED IMMUNE RESPONSE$203,634
R01 · FY2000 · AI